The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 26, 2022
Filed:
Apr. 06, 2020
Applicant:
Zealand Pharma A/s, Søborg, DK;
Inventors:
Bjarne Due Larsen, Roskilde, DK;
Jonathan Griffin, Lund, SE;
Lise Giehm, Frederiksberg, DK;
Alistair Vincent Gordon Edwards, Copenhagen S, DK;
Assignee:
Zealand Pharma A/S, Søborg, DK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/26 (2006.01); C07K 14/605 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/26 (2013.01); A61P 3/04 (2018.01); A61P 3/10 (2018.01); C07K 14/605 (2013.01); A61K 38/00 (2013.01);
Abstract
A compound having agonist activity at the GLP-1 (glucagon-like-peptide 1) and GLP-2 (glucagon-like peptide 2) receptors, and a pharmaceutical composition containing the compound or a pharmaceutically acceptable salt or solvate thereof in admixture with a pharmaceutically acceptable carrier, an excipient or a vehicle are provided. The compound can be used, inter alia, in the prophylaxis or treatment of intestinal damage and dysfunction, regulation of body weight, and prophylaxis or treatment of metabolic dysfunction.